Guideline-concordant antibiotic prescribing for community-acquired bacterial pneumonia (CABP) due to drug-resistant pathogens in the <i>All of Us</i> database
In the <i>All of Us</i> database, the majority of CABP-MRSA and CABP-<i>P. aeruginosa</i> patients were prescribed guideline-concordant antibiotic therapy. Race was independently predictive of guideline-concordant antibiotic therapy for patients with CABP-<i>P. aeruginosa</i>, but not CABP-MRSA. NHB patients were less likely to receive guideline-concordant antibiotic therapy than NHW patients when treated for CABP-<i>P. aeruginosa.</i>
Authors
- Corbyn M. Gilmore (ORCID: https://orcid.org/0000-0003-3847-3674)
- Susanne Schmidt (ORCID: https://orcid.org/0000-0001-7684-1648)
- Christopher R. Frei (ORCID: https://orcid.org/0000-0002-0692-4787)
- Kelly R. Reveles (ORCID: https://orcid.org/0000-0001-8880-4879)
- Adriana Vargus
- Carlos A. Álvarez (ORCID: https://orcid.org/0000-0002-9512-1870)
- Grace C. Lee (ORCID: https://orcid.org/0000-0002-7653-3028)
Institutions
- Texas Tech University (US)
- The University of Texas at San Antonio Health Science Center (US)
- San Antonio Regional Hospital (US)
- South Texas Veterans Health Care System (US)
- The University of Texas at San Antonio (US)
- The University of Texas at Austin (US)
- Texas Tech University Health Sciences Center (US)
Publication Details
- Journal
- Journal of Clinical and Translational Science
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/cts.2025.10143
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Cambridge
- National Institutes of Health
- National Center for Advancing Translational Sciences